According to Anavex Life Sciences 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -S$60.01 Million, an increase over its 2022 earnings that were of -S$72.86 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2024 (TTM) | -S$60.71 Million | 1.16% |
2023 | -S$60.01 Million | -17.65% |
2022 | -S$72.86 Million | 22.96% |
2021 | -S$59.26 Million | 35.36% |
2020 | -S$43.78 Million | 12.65% |
2019 | -S$38.86 Million | 29.09% |
2018 | -S$30.1 Million | 36.33% |
2017 | -S$22.08 Million | 17.11% |
2016 | -S$18.86 Million | 20.91% |
2015 | -S$15.6 Million | -6.29% |
2014 | -S$16.64 Million | 337.28% |
2013 | -S$3.81 Million | |
2008 | -S$7.04 Million | 106.01% |
2007 | -S$3.42 Million | 8848.98% |
2006 | -S$0.04 Million | -79.99% |
2005 | -S$0.2 Million |